AstraZeneca Open Innovation: Innovation through collaboration


The Open Innovation Team from AstraZeneca, a world-leading biopharmaceutical company, is holding an information session on its Open Innovation program. The program is designed to create an ecosystem of open collaboration between AstraZeneca and external partners.

Representatives from the company will share their strategic interest areas as well as the collaboration programs they have available. The company has identified the following particular areas of interest in innovation:

  • Biology
  • Translational science
  • Drug delivery
  • Regenerative medicine
  • Preclinical research


AstraZeneca has opportunities ranging from basic, early-stage research through applications to clinical stage research. Join this vritual seminar to find out more about how to collaborate with this exciting company. Speakers for the event will be Pam Hill, Senior Director, Global Head of Open Innovation and Saghar Nourian, Associate Director, Open Innovation Lead.

To register for this virtual event, please follow this link.

Learn more and register


Contact Information

Contact: Janet Prince
Organization: Innovation & Partnerships
Office Phone: 514-398-4102

Copyright © 2019 McGill Regenerative Medicine Network. All rights reserved. Website by KORSR Studio, Valérie Provost & ER5.